Tango Therapeutics Inc (TNGX)

Jul 28, 2026

Tango Therapeutics Inc (TNGX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 28, 2026

Jul 28, 2026

Tango Therapeutics Inc (TNGX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 28, 2026

Jul 25, 2026

Tango Therapeutics Inc (TNGX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 25, 2026

Jul 25, 2026

TradingKey - TradingKey

Jul 25, 2026

Jul 25, 2026

Tango Therapeutics Inc (TNGX) Cash Flow - TradingKey

Jul 25, 2026

Jul 24, 2026

Tango Therapeutics Inc (TNGX) Institutional Confidence - TradingKey

Jul 24, 2026

Jul 23, 2026

TNGX: Tango Therapeutics Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Jul 23, 2026

Jul 23, 2026

Tango Therapeutics, Inc. (TNGX) stock price, news, quote and history - Yahoo Finance UK

Jul 23, 2026

Jul 23, 2026

Tango Therapeutics, Inc. (TNGX) Stock Price, News, Quote & History - Yahoo! Finance Canada

Jul 23, 2026

Jul 23, 2026

CCORF Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Maintains Target Price $46 - Moomoo

Jul 23, 2026

Jul 23, 2026

Tango Therapeutics Inc (TNGX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jul 23, 2026

Jul 22, 2026

How Much Upside is Left in Tango Therapeutics (TNGX)? Wall Street Analysts Think 49.48% - Yahoo Finance Singapore

Jul 22, 2026

Jul 22, 2026

TNGX Stock Crashes 20% After Reporting $0 Revenue In Q1 — But Analysts Still See Massive Upside - Stocktwits

Jul 22, 2026

Jul 18, 2026

Mizuho Raises Price Target on Tango Therapeutics to $40 From $36, Keeps Outperform Rating - Moomoo

Jul 18, 2026

Jul 17, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jul 17, 2026

Jul 17, 2026

TNGX Maintained by Mizuho -- Price Target Raised to $40.00 - GuruFocus

Jul 17, 2026

Jul 17, 2026

Mizuho raises Tango Therapeutics stock price target on combo data - Investing.com

Jul 17, 2026

Jul 17, 2026

Mizuho raises Tango Therapeutics stock price target on combo data By Investing.com - Investing.com Nigeria

Jul 17, 2026

Jul 16, 2026

This Veracyte Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Sahm

Jul 16, 2026

Jul 15, 2026

JPMorgan initiates Tango Therapeutics stock at Overweight By Investing.com - Investing.com Australia

Jul 15, 2026

Jul 15, 2026

JPMorgan initiates Tango Therapeutics stock at Overweight - Investing.com UK

Jul 15, 2026

Jul 15, 2026

Tango Therapeutics (TNGX) to Benefit From Vopimetostat + KRAS Inhibitors Combined Revenues - Yahoo Finance

Jul 15, 2026

Jul 15, 2026

TNGX Initiates Coverage On JP Morgan -- Rating Set to Overweight - GuruFocus

Jul 15, 2026

Jul 15, 2026

JPMorgan Initiates Coverage on Tango Therapeutics With Overweight Rating, $46 Price Target - marketscreener.com

Jul 15, 2026

Jul 15, 2026

J.P. Morgan Initiates Tango Therapeutics(TNGX.US) With Buy Rating, Announces Target Price $46 - Moomoo

Jul 15, 2026

Jul 13, 2026

Tango Therapeutics Inc (TNGX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 13, 2026

Jul 10, 2026

Top Hyperliquid Strategies (PURR) Competitors 2026 - MarketBeat

Jul 10, 2026

Jul 10, 2026

2 Monster Growth Stocks Analysts Think Can Reach New Highs - The Globe and Mail

Jul 10, 2026

Jul 09, 2026

Does Tango Therapeutics' (TNGX) Russell Growth Shift Reveal Its True Biotech Identity to Institutions? - simplywall.st

Jul 09, 2026

Jul 03, 2026

Form 4 Tango Therapeutics Inc For: 2 July By Investing.com - Investing.com UK

Jul 03, 2026

Jul 02, 2026

Tango Therapeutics president Crystal Adam sells $798,908 in stock By Investing.com - Investing.com South Africa

Jul 02, 2026

Jul 02, 2026

Tango Therapeutics president Crystal Adam sells $798,908 in stock - Investing.com

Jul 02, 2026

Jul 02, 2026

Tango Therapeutics (TNGX) R&D president exercises options and sells 27,000 shares - Stock Titan

Jul 02, 2026

Jul 02, 2026

Price to book forward of Tango Therapeutics, Inc. – NASDAQ:TNGX - TradingView

Jul 02, 2026

Jul 02, 2026

Tango Therapeutics Rides a New Precision Oncology Trend in 2026 - Yahoo Finance

Jul 02, 2026

Jul 02, 2026

Is TNGX Stock Still Worth Buying After Its Huge Rally in 2026? - Yahoo Finance

Jul 02, 2026

Jul 02, 2026

TNGX Stock Outlook Hinges on Vopimetostat and Key 2026 Catalysts - Yahoo Finance

Jul 02, 2026

Jun 30, 2026

TNGX Q1 2026 Earnings: Net Loss Slightly Misses Estimates as Pre-Revenue Biotech Advances PipelineHigh Growth Earnings - dars.gov.et

Jun 30, 2026

Jun 30, 2026

TNGX Maintained by Canaccord Genuity -- Price Target Raised to $46 - GuruFocus

Jun 30, 2026

Jun 29, 2026

Tango Therapeutics, Inc.(NasdaqGM: TNGX) added to Russell 2500 Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Top Damora Therapeutics, Inc. Common Stock (DMRA) Competitors 2026 - MarketBeat

Jun 29, 2026

Jun 29, 2026

CCORF Maintains Tango Therapeutics(TNGX.US) With Buy Rating, Raises Target Price to $46 - Moomoo

Jun 29, 2026

Jun 29, 2026

Tango Therapeutics, Inc.(NasdaqGM: TNGX) added to Russell 2000 Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Tango Therapeutics, Inc.(NasdaqGM:TNGX) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Tango Therapeutics, Inc.(NasdaqGM: TNGX) added to Russell 3000E Growth Benchmark - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Tango Therapeutics, Inc.(NasdaqGM: TNGX) dropped from Russell 3000 Value Benchmark - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Tango Therapeutics, Inc.(NasdaqGM: TNGX) dropped from Russell 3000E Index - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Tango Therapeutics, Inc.(NasdaqGM: TNGX) dropped from Russell Microcap Index - marketscreener.com

Jun 29, 2026

Jun 28, 2026

Tango Therapeutics, Inc.(NasdaqGM: TNGX) dropped from Russell 2500 Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 28, 2026

Tango Therapeutics, Inc.(NasdaqGM:TNGX) dropped from Russell Microcap Value Benchmark Index - marketscreener.com

Jun 28, 2026